Montreal Cognitive Assessment (MoCA): validation study for frontotemporal dementia

Area of Science:

• Neuroscience
• Cognitive Psychology
• Gerontology

Background:

• The Montreal Cognitive Assessment (MoCA) is a screening tool for mild cognitive impairment.
• The Mini-Mental State Examination (MMSE) has limitations in detecting milder cognitive deficits.
• Behavioral-variant frontotemporal dementia (bv-FTD) presents unique cognitive challenges.

Purpose of the Study:

• To validate the MoCA as a cognitive screening test for bv-FTD.
• To examine the psychometric properties and diagnostic accuracy of MoCA in bv-FTD.
• To compare MoCA's performance against the MMSE for bv-FTD screening.

Main Methods:

• A study involving three matched participant groups: bv-FTD (n=50), Alzheimer disease (n=50), and healthy controls (n=50).
• Psychometric properties and diagnostic accuracy of MoCA and MMSE were evaluated.
• Comparison of sensitivity, specificity, and predictive values at a MoCA cutoff of <17.

Main Results:

• MoCA demonstrated superior psychometric properties and discriminant capacity compared to MMSE.
• MoCA achieved a high diagnostic accuracy for bv-FTD (AUC = 0.934) versus MMSE (AUC = 0.772).
• MoCA showed significantly better sensitivity, specificity, and predictive values than MMSE for bv-FTD detection.

Conclusions:

• MoCA is a sensitive and accurate instrument for screening bv-FTD.
• MoCA offers a better alternative to MMSE for cognitive screening in bv-FTD.
• The findings support MoCA's utility in identifying milder cognitive impairments characteristic of bv-FTD.